Prolific Machines, with a $55M Series B, shines 'light' on a better way to grow lab proteins for food and medicine | TechCrunch
Briefly

Prolific Machines introduces a bioreactor utilizing light to control cell growth, aiming to replace traditional methods reliant on expensive molecules like chemicals or proteins.
Current methods which use expensive recombinant proteins for cell production are imprecise, making it challenging to control growth. Prolific Machines transitions to a light-based solution for better precision and efficiency.
Read at TechCrunch
[
add
]
[
|
|
]